Related Experiment Videos
Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients
Morris B Goldman1, Gordon Wood, Megan B Goldman
1Department of Psychiatry, University of Chicago and Psychiatric Institute, Chicago, Illinois 60637, USA. m-goldman@uchicago.edu
The Journal of Clinical Endocrinology and Metabolism
|November 23, 2006
Summary
Schizophrenia patients with primary polydipsia, especially those with hyponatremia, show impaired glucocorticoid negative feedback. This dysfunction suggests hippocampal mineralocorticoid abnormalities in these patients.
Area of Science:
- Neuroendocrinology
- Psychiatry
Background:
- Diminished glucocorticoid negative feedback is observed in schizophrenia, particularly in patients with primary polydipsia.
- Hyponatremic polydipsic patients exhibit neuroendocrine abnormalities linked to hippocampal pathology.
Purpose of the Study:
- To investigate the effect of cortisol on plasma ACTH.
- To assess glucocorticoid feedback under conditions sensitive to hippocampal influence.
Main Methods:
- Repeated measures design at an inpatient clinical research center.
- Administration of metyrapone and hydrocortisone infusion.
- Measurement of plasma ACTH and cortisol levels in patient groups and healthy volunteers.
Main Results:
- Polydipsic hyponatremic patients showed no significant ACTH decline during cortisol infusion.
- Elevated ACTH levels were observed in hyponatremic patients for any given cortisol level.
- Other groups exhibited cortisol-induced ACTH decline, most pronounced in non-water-imbalanced patients.
Conclusions:
- Marked impairment of glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients.
- Findings are consistent with hippocampal mineralocorticoid dysfunction in this patient group.
Related Concept Videos
Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Diabetes Insipidus II: Pathophysiology
Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...